ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ENLV Enlivex Therapeutics Ltd

1.44
-0.05 (-3.36%)
Pre Market
Last Updated: 04:46:34
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -6.4M-5.87M-5.68M-7.85M-6.78M-6.65M-5.63M-6.09M
Pre Tax Income -8.23M-9.91M-5.73M-7.19M-7.22M-6.79M-5.96M-9.1M
Net Income -8.23M-9.91M-5.73M-7.19M-7.22M-6.79M-5.96M-9.1M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -8.23M-9.91M-5.73M-7.85M-7.22M-6.79M-5.96M-10.34M
EBITDA -6.22M-5.88M-5.3M-7.62M-6.57M-6.44M-5.41M-5.89M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -15.85M-2.17M-5.3M-8.62M-9.79M-19.29M-25.8M-25.15M
Pre Tax Income -15.81M-2.5M-4.24M-9.38M-11.82M-14.47M-31.06M-29.07M
Net Income -16.02M-2.5M-4.24M-9.38M-11.82M-14.47M-31.06M-29.07M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.945-0.641-0.47-0.592-0.588-0.606-1.297-1.205
EBIT -15.87M-2.19M-5.3M-8.62M-9.79M-19.29M-25.8M-29.4M
EBITDA -15.83M-2.09M-5.18M-8.41M-9.5M-18.74M-25.02M-24.32M

Your Recent History

Delayed Upgrade Clock